nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisacodyl—GPR55—adrenal gland—obesity	0.0275	0.536	CbGeAlD
Bisacodyl—GPR55—endocrine gland—obesity	0.0238	0.465	CbGeAlD
Bisacodyl—Abdominal cramps—Phentermine—obesity	0.0205	0.0609	CcSEcCtD
Bisacodyl—Anorectal discomfort—Orlistat—obesity	0.0116	0.0344	CcSEcCtD
Bisacodyl—Abdominal discomfort—Diethylpropion—obesity	0.00724	0.0215	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Methamphetamine—obesity	0.00593	0.0176	CcSEcCtD
Bisacodyl—Colitis—Sibutramine—obesity	0.00588	0.0175	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Benzphetamine—obesity	0.00572	0.017	CcSEcCtD
Bisacodyl—Colitis—Bupropion—obesity	0.00512	0.0152	CcSEcCtD
Bisacodyl—Hypersensitivity—Methamphetamine—obesity	0.00506	0.015	CcSEcCtD
Bisacodyl—Hypersensitivity—Benzphetamine—obesity	0.00488	0.0145	CcSEcCtD
Bisacodyl—Abdominal pain—Phendimetrazine—obesity	0.00478	0.0142	CcSEcCtD
Bisacodyl—Diarrhoea—Methamphetamine—obesity	0.0047	0.014	CcSEcCtD
Bisacodyl—Dizziness—Methamphetamine—obesity	0.00455	0.0135	CcSEcCtD
Bisacodyl—Diarrhoea—Benzphetamine—obesity	0.00453	0.0135	CcSEcCtD
Bisacodyl—Dizziness—Benzphetamine—obesity	0.00438	0.013	CcSEcCtD
Bisacodyl—Headache—Methamphetamine—obesity	0.00431	0.0128	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Phentermine—obesity	0.00426	0.0127	CcSEcCtD
Bisacodyl—Headache—Benzphetamine—obesity	0.00415	0.0123	CcSEcCtD
Bisacodyl—Cramp muscle—Orlistat—obesity	0.00413	0.0123	CcSEcCtD
Bisacodyl—Diarrhoea—Phendimetrazine—obesity	0.00413	0.0123	CcSEcCtD
Bisacodyl—Dehydration—Sibutramine—obesity	0.00413	0.0123	CcSEcCtD
Bisacodyl—Anaphylactic shock—Cimetidine—obesity	0.00409	0.0121	CcSEcCtD
Bisacodyl—Dizziness—Phendimetrazine—obesity	0.00399	0.0119	CcSEcCtD
Bisacodyl—Nausea—Benzphetamine—obesity	0.00394	0.0117	CcSEcCtD
Bisacodyl—Abdominal pain—Phentermine—obesity	0.0039	0.0116	CcSEcCtD
Bisacodyl—Abdominal discomfort—Orlistat—obesity	0.0038	0.0113	CcSEcCtD
Bisacodyl—Hypersensitivity—Phenylpropanolamine—obesity	0.0038	0.0113	CcSEcCtD
Bisacodyl—Headache—Phendimetrazine—obesity	0.00378	0.0112	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Diethylpropion—obesity	0.00371	0.011	CcSEcCtD
Bisacodyl—Dehydration—Bupropion—obesity	0.0036	0.0107	CcSEcCtD
Bisacodyl—Nausea—Phendimetrazine—obesity	0.00359	0.0107	CcSEcCtD
Bisacodyl—Cramp muscle—Bupropion—obesity	0.00349	0.0104	CcSEcCtD
Bisacodyl—Dizziness—Phenylpropanolamine—obesity	0.00341	0.0101	CcSEcCtD
Bisacodyl—Diarrhoea—Phentermine—obesity	0.00338	0.01	CcSEcCtD
Bisacodyl—Vomiting—Phenylpropanolamine—obesity	0.00328	0.00975	CcSEcCtD
Bisacodyl—Dizziness—Phentermine—obesity	0.00327	0.0097	CcSEcCtD
Bisacodyl—Abdominal discomfort—Bupropion—obesity	0.00321	0.00954	CcSEcCtD
Bisacodyl—Vomiting—Phentermine—obesity	0.00314	0.00933	CcSEcCtD
Bisacodyl—Headache—Phentermine—obesity	0.00309	0.00919	CcSEcCtD
Bisacodyl—Nausea—Phenylpropanolamine—obesity	0.00307	0.00911	CcSEcCtD
Bisacodyl—Hypersensitivity—Cimetidine—obesity	0.00301	0.00895	CcSEcCtD
Bisacodyl—Diarrhoea—Diethylpropion—obesity	0.00294	0.00873	CcSEcCtD
Bisacodyl—Nausea—Phentermine—obesity	0.00293	0.00872	CcSEcCtD
Bisacodyl—Immune system disorder—Orlistat—obesity	0.00287	0.00853	CcSEcCtD
Bisacodyl—Dizziness—Diethylpropion—obesity	0.00284	0.00844	CcSEcCtD
Bisacodyl—Diarrhoea—Cimetidine—obesity	0.0028	0.00831	CcSEcCtD
Bisacodyl—Immune system disorder—Sibutramine—obesity	0.00278	0.00825	CcSEcCtD
Bisacodyl—Malnutrition—Orlistat—obesity	0.00277	0.00822	CcSEcCtD
Bisacodyl—Vomiting—Diethylpropion—obesity	0.00273	0.00812	CcSEcCtD
Bisacodyl—Dizziness—Cimetidine—obesity	0.0027	0.00803	CcSEcCtD
Bisacodyl—Headache—Diethylpropion—obesity	0.00269	0.008	CcSEcCtD
Bisacodyl—Malnutrition—Sibutramine—obesity	0.00268	0.00795	CcSEcCtD
Bisacodyl—Muscle spasms—Orlistat—obesity	0.00266	0.0079	CcSEcCtD
Bisacodyl—Vomiting—Cimetidine—obesity	0.0026	0.00772	CcSEcCtD
Bisacodyl—Muscle spasms—Sibutramine—obesity	0.00257	0.00765	CcSEcCtD
Bisacodyl—Headache—Cimetidine—obesity	0.00256	0.00761	CcSEcCtD
Bisacodyl—Nausea—Diethylpropion—obesity	0.00255	0.00758	CcSEcCtD
Bisacodyl—Angioedema—Orlistat—obesity	0.00253	0.00751	CcSEcCtD
Bisacodyl—Angioedema—Sibutramine—obesity	0.00245	0.00727	CcSEcCtD
Bisacodyl—Nausea—Cimetidine—obesity	0.00243	0.00722	CcSEcCtD
Bisacodyl—Immune system disorder—Bupropion—obesity	0.00242	0.00719	CcSEcCtD
Bisacodyl—Syncope—Sibutramine—obesity	0.0024	0.00713	CcSEcCtD
Bisacodyl—Loss of consciousness—Sibutramine—obesity	0.00235	0.00699	CcSEcCtD
Bisacodyl—Malnutrition—Bupropion—obesity	0.00233	0.00693	CcSEcCtD
Bisacodyl—Dehydration—Topiramate—obesity	0.0023	0.00682	CcSEcCtD
Bisacodyl—Anaphylactic shock—Orlistat—obesity	0.00226	0.00671	CcSEcCtD
Bisacodyl—Muscle spasms—Bupropion—obesity	0.00224	0.00667	CcSEcCtD
Bisacodyl—Nervous system disorder—Orlistat—obesity	0.00221	0.00658	CcSEcCtD
Bisacodyl—Anaphylactic shock—Sibutramine—obesity	0.00218	0.00649	CcSEcCtD
Bisacodyl—Shock—Sibutramine—obesity	0.00215	0.00639	CcSEcCtD
Bisacodyl—Chlorphenamine—SLC22A1—obesity	0.00214	0.358	CrCbGaD
Bisacodyl—Angioedema—Bupropion—obesity	0.00213	0.00633	CcSEcCtD
Bisacodyl—Syncope—Bupropion—obesity	0.00209	0.00622	CcSEcCtD
Bisacodyl—Loss of consciousness—Bupropion—obesity	0.00205	0.00609	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—IAPP—obesity	0.00205	0.00338	CbGpPWpGaD
Bisacodyl—Abdominal discomfort—Topiramate—obesity	0.00204	0.00608	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—HTR1B—obesity	0.00199	0.00328	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CRH—obesity	0.00199	0.00328	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Orlistat—obesity	0.00195	0.00579	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—APLN—obesity	0.00194	0.0032	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PYY—obesity	0.00194	0.0032	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PMCH—obesity	0.00193	0.00319	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—HCRT—obesity	0.00193	0.00319	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—NMU—obesity	0.00193	0.00319	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—NPY5R—obesity	0.00193	0.00319	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—ADRB2—obesity	0.0019	0.00314	CbGpPWpGaD
Bisacodyl—Anaphylactic shock—Bupropion—obesity	0.0019	0.00566	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—KIF7—obesity	0.00189	0.00312	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MKS1—obesity	0.00189	0.00312	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Sibutramine—obesity	0.00189	0.0056	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—NPS—obesity	0.00189	0.00311	CbGpPWpGaD
Bisacodyl—Shock—Bupropion—obesity	0.00187	0.00557	CcSEcCtD
Bisacodyl—GPR55—G alpha (i) signalling events—C3—obesity	0.00187	0.00309	CbGpPWpGaD
Bisacodyl—Nervous system disorder—Bupropion—obesity	0.00187	0.00555	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—NPY2R—obesity	0.00185	0.00306	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—MC3R—obesity	0.00185	0.00306	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—NPY1R—obesity	0.00185	0.00306	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—MC4R—obesity	0.00185	0.00306	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—DRD1—obesity	0.00185	0.00305	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—HTR2C—obesity	0.00185	0.00305	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Orlistat—obesity	0.00185	0.00548	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—PPY—obesity	0.00182	0.003	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—ADRB1—obesity	0.00179	0.00295	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Sibutramine—obesity	0.00179	0.00531	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—PRKCH—obesity	0.00179	0.00295	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—GIP—obesity	0.00179	0.00295	CbGpPWpGaD
Bisacodyl—Abdominal pain—Orlistat—obesity	0.00178	0.0053	CcSEcCtD
Bisacodyl—GPR55—G alpha (i) signalling events—AGT—obesity	0.00178	0.00293	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—NPY5R—obesity	0.00176	0.0029	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—NMU—obesity	0.00176	0.0029	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PMCH—obesity	0.00176	0.0029	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—HCRT—obesity	0.00176	0.0029	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—GHRL—obesity	0.00175	0.00289	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—DRD4—obesity	0.00174	0.00287	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PRLH—obesity	0.00173	0.00286	CbGpPWpGaD
Bisacodyl—Abdominal pain—Sibutramine—obesity	0.00173	0.00513	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCL5—obesity	0.00169	0.00279	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—MC4R—obesity	0.00168	0.00278	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—NPY1R—obesity	0.00168	0.00278	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—NPY2R—obesity	0.00168	0.00278	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—MC3R—obesity	0.00168	0.00278	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Orlistat—obesity	0.00166	0.00494	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—CNR1—obesity	0.00166	0.00274	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PPY—obesity	0.00165	0.00272	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Bupropion—obesity	0.00164	0.00488	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—PRKCH—obesity	0.00162	0.00267	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—GIP—obesity	0.00162	0.00267	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—DRD2—obesity	0.00162	0.00267	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Sibutramine—obesity	0.00161	0.00478	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—GCG—obesity	0.0016	0.00264	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Bupropion—obesity	0.00156	0.00463	CcSEcCtD
Bisacodyl—Diarrhoea—Orlistat—obesity	0.00154	0.00459	CcSEcCtD
Bisacodyl—Immune system disorder—Topiramate—obesity	0.00154	0.00458	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—ADRB3—obesity	0.00152	0.0025	CbGpPWpGaD
Bisacodyl—Abdominal pain—Bupropion—obesity	0.00151	0.00447	CcSEcCtD
Bisacodyl—GPR55—G alpha (i) signalling events—POMC—obesity	0.0015	0.00247	CbGpPWpGaD
Bisacodyl—Diarrhoea—Sibutramine—obesity	0.00149	0.00444	CcSEcCtD
Bisacodyl—Dizziness—Orlistat—obesity	0.00149	0.00443	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—HTR2A—obesity	0.00149	0.00246	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—C3—obesity	0.00149	0.00245	CbGpPWpGaD
Bisacodyl—Malnutrition—Topiramate—obesity	0.00149	0.00442	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—GAL—obesity	0.00148	0.00245	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—C5AR1—obesity	0.00147	0.00242	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—ADRB2—obesity	0.00145	0.00239	CbGpPWpGaD
Bisacodyl—Dizziness—Sibutramine—obesity	0.00144	0.00429	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—GHRH—obesity	0.00144	0.00237	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NMB—obesity	0.00144	0.00237	CbGpPWpGaD
Bisacodyl—Vomiting—Orlistat—obesity	0.00143	0.00426	CcSEcCtD
Bisacodyl—Muscle spasms—Topiramate—obesity	0.00143	0.00425	CcSEcCtD
Bisacodyl—Headache—Orlistat—obesity	0.00141	0.0042	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—AGT—obesity	0.00141	0.00233	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Bupropion—obesity	0.0014	0.00417	CcSEcCtD
Bisacodyl—Carbinoxamine—CYP2E1—obesity	0.00139	0.233	CrCbGaD
Bisacodyl—Vomiting—Sibutramine—obesity	0.00139	0.00413	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—GNB3—obesity	0.00138	0.00228	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ADRB3—obesity	0.00138	0.00227	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—FFAR4—obesity	0.00137	0.00226	CbGpPWpGaD
Bisacodyl—Headache—Sibutramine—obesity	0.00137	0.00407	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—GAL—obesity	0.00135	0.00222	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—GNAS—obesity	0.00135	0.00222	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CCK—obesity	0.00134	0.00221	CbGpPWpGaD
Bisacodyl—Nausea—Orlistat—obesity	0.00134	0.00398	CcSEcCtD
Bisacodyl—Syncope—Topiramate—obesity	0.00133	0.00396	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—C5AR1—obesity	0.00133	0.0022	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GHSR—obesity	0.00131	0.00217	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MCHR1—obesity	0.00131	0.00217	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—BRS3—obesity	0.00131	0.00217	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—GLP1R—obesity	0.00131	0.00216	CbGpPWpGaD
Bisacodyl—Loss of consciousness—Topiramate—obesity	0.00131	0.00388	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—F2—obesity	0.00131	0.00215	CbGpPWpGaD
Bisacodyl—Diarrhoea—Bupropion—obesity	0.0013	0.00387	CcSEcCtD
Bisacodyl—Nausea—Sibutramine—obesity	0.0013	0.00386	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—CCL5—obesity	0.00129	0.00212	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—HRH3—obesity	0.00129	0.00212	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CCKAR—obesity	0.00129	0.00212	CbGpPWpGaD
Bisacodyl—Dizziness—Bupropion—obesity	0.00126	0.00374	CcSEcCtD
Bisacodyl—Chlorphenamine—SLC6A4—obesity	0.00124	0.207	CrCbGaD
Bisacodyl—GPR55—Signaling Pathways—PRLHR—obesity	0.00122	0.00201	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GH1—obesity	0.00122	0.00201	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SH2B1—obesity	0.00122	0.00201	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCK—obesity	0.00122	0.00201	CbGpPWpGaD
Bisacodyl—Vomiting—Bupropion—obesity	0.00121	0.0036	CcSEcCtD
Bisacodyl—Brompheniramine—CYP2E1—obesity	0.00121	0.202	CrCbGaD
Bisacodyl—Shock—Topiramate—obesity	0.00119	0.00355	CcSEcCtD
Bisacodyl—Headache—Bupropion—obesity	0.00119	0.00354	CcSEcCtD
Bisacodyl—Nervous system disorder—Topiramate—obesity	0.00119	0.00354	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—POMC—obesity	0.00119	0.00196	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—GLP1R—obesity	0.00119	0.00196	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCKAR—obesity	0.00117	0.00193	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—HRH3—obesity	0.00117	0.00193	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—NPY—obesity	0.00116	0.00192	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCL2—obesity	0.00116	0.00192	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—IAPP—obesity	0.00116	0.00191	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—APLN—obesity	0.00115	0.00189	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PYY—obesity	0.00115	0.00189	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—HTR2A—obesity	0.00113	0.00187	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—C3—obesity	0.00113	0.00187	CbGpPWpGaD
Bisacodyl—Nausea—Bupropion—obesity	0.00113	0.00336	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—PRKAR2B—obesity	0.00112	0.00185	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—HTR1B—obesity	0.00112	0.00185	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CRH—obesity	0.00112	0.00185	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PNLIP—obesity	0.00109	0.00179	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—AGT—obesity	0.00108	0.00177	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—NPS—obesity	0.00107	0.00176	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SDC3—obesity	0.00106	0.00175	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—NPY—obesity	0.00106	0.00174	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—IAPP—obesity	0.00105	0.00173	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Topiramate—obesity	0.00105	0.00311	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—DRD1—obesity	0.00104	0.00172	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—HTR2C—obesity	0.00104	0.00172	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NMU—obesity	0.00104	0.00171	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PMCH—obesity	0.00104	0.00171	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HCRT—obesity	0.00104	0.00171	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NPY5R—obesity	0.00104	0.00171	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—HTR1B—obesity	0.00102	0.00168	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CRH—obesity	0.00102	0.00168	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—ADRB1—obesity	0.00101	0.00167	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NPY1R—obesity	0.000995	0.00164	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MC3R—obesity	0.000995	0.00164	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MC4R—obesity	0.000995	0.00164	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NPY2R—obesity	0.000995	0.00164	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—F2—obesity	0.000994	0.00164	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Topiramate—obesity	0.000992	0.00295	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—GHRL—obesity	0.00099	0.00163	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—DRD4—obesity	0.000982	0.00162	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PPY—obesity	0.000976	0.00161	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—NPS—obesity	0.000967	0.0016	CbGpPWpGaD
Bisacodyl—Abdominal pain—Topiramate—obesity	0.000959	0.00285	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—PRKCH—obesity	0.000958	0.00158	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GIP—obesity	0.000958	0.00158	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HDAC8—obesity	0.000958	0.00158	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—DRD1—obesity	0.000949	0.00156	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—HTR2C—obesity	0.000949	0.00156	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CNR1—obesity	0.000938	0.00155	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ADRB1—obesity	0.000919	0.00152	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—DRD2—obesity	0.000915	0.00151	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—LEPR—obesity	0.00091	0.0015	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—GCG—obesity	0.000906	0.00149	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—POMC—obesity	0.000906	0.00149	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—GHRL—obesity	0.000899	0.00148	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Topiramate—obesity	0.000894	0.00266	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—DRD4—obesity	0.000892	0.00147	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CCL2—obesity	0.000886	0.00146	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CNR1—obesity	0.000852	0.0014	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—DRD2—obesity	0.000831	0.00137	CbGpPWpGaD
Bisacodyl—Diarrhoea—Topiramate—obesity	0.00083	0.00247	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—GCG—obesity	0.000823	0.00136	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—ADRB2—obesity	0.00082	0.00135	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ADRB3—obesity	0.000814	0.00134	CbGpPWpGaD
Bisacodyl—Dizziness—Topiramate—obesity	0.000802	0.00238	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—GAL—obesity	0.000795	0.00131	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—C5AR1—obesity	0.000787	0.0013	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—GNB3—obesity	0.000781	0.00129	CbGpPWpGaD
Bisacodyl—Vomiting—Topiramate—obesity	0.000771	0.00229	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—GNAS—obesity	0.00076	0.00125	CbGpPWpGaD
Bisacodyl—Headache—Topiramate—obesity	0.00076	0.00226	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—ADRB2—obesity	0.000744	0.00123	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CCL5—obesity	0.000727	0.0012	CbGpPWpGaD
Bisacodyl—Nausea—Topiramate—obesity	0.000721	0.00214	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCK—obesity	0.000719	0.00119	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PRKG1—obesity	0.000719	0.00119	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—GNB3—obesity	0.000709	0.00117	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—RBP4—obesity	0.000701	0.00116	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GLP1R—obesity	0.000701	0.00116	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—GNAS—obesity	0.00069	0.00114	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HRH3—obesity	0.00069	0.00114	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCKAR—obesity	0.00069	0.00114	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PRKAR2B—obesity	0.000664	0.0011	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCL5—obesity	0.00066	0.00109	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PRKCD—obesity	0.000655	0.00108	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NCF2—obesity	0.000641	0.00106	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—HTR2A—obesity	0.000641	0.00106	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—C3—obesity	0.00064	0.00106	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NPY—obesity	0.000625	0.00103	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—APOC3—obesity	0.000621	0.00102	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IAPP—obesity	0.000621	0.00102	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—AGT—obesity	0.000608	0.001	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CRH—obesity	0.000603	0.000994	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HTR1B—obesity	0.000603	0.000994	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SDC1—obesity	0.000596	0.000983	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PRKCD—obesity	0.000595	0.000981	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AKR1C3—obesity	0.000586	0.000967	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—HTR2A—obesity	0.000582	0.00096	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—C3—obesity	0.000581	0.000959	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NPS—obesity	0.000571	0.000943	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PRKCB—obesity	0.000562	0.000927	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—F2—obesity	0.000562	0.000927	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HTR2C—obesity	0.00056	0.000924	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—DRD1—obesity	0.00056	0.000924	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—AGT—obesity	0.000552	0.000911	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NTRK2—obesity	0.000545	0.000899	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ADRB1—obesity	0.000543	0.000895	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PIK3CG—obesity	0.000538	0.000887	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GHRL—obesity	0.000531	0.000876	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PARP1—obesity	0.000531	0.000876	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—DRD4—obesity	0.000527	0.000869	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—POMC—obesity	0.000512	0.000844	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PRKCB—obesity	0.00051	0.000842	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—F2—obesity	0.00051	0.000842	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CNR1—obesity	0.000503	0.00083	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—TCF7L2—obesity	0.000494	0.000815	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—AKT2—obesity	0.000492	0.000812	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—DRD2—obesity	0.000491	0.00081	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PIK3CG—obesity	0.000488	0.000805	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PTPN1—obesity	0.000486	0.000802	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GCG—obesity	0.000486	0.000802	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PIK3CD—obesity	0.000473	0.00078	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—POMC—obesity	0.000465	0.000767	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PRL—obesity	0.000464	0.000765	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—STK11—obesity	0.000457	0.000754	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCL2—obesity	0.000455	0.00075	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PLG—obesity	0.000452	0.000745	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—RHOA—obesity	0.000451	0.000744	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—AKT2—obesity	0.000447	0.000737	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PIK3R1—obesity	0.000446	0.000736	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—FOXO3—obesity	0.000441	0.000727	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ADRB2—obesity	0.00044	0.000725	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SOCS1—obesity	0.000433	0.000714	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PIK3CD—obesity	0.000429	0.000708	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SOCS3—obesity	0.000428	0.000706	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GNB3—obesity	0.000419	0.000691	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—TYK2—obesity	0.000413	0.000681	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PIK3CB—obesity	0.000412	0.00068	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IGF2—obesity	0.000411	0.000679	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—RHOA—obesity	0.00041	0.000676	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GNAS—obesity	0.000408	0.000673	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PIK3R1—obesity	0.000405	0.000669	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—APOB—obesity	0.000399	0.000659	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCL5—obesity	0.00039	0.000643	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—LPL—obesity	0.000381	0.000629	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—FOXO1—obesity	0.000379	0.000624	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—RPS6KB1—obesity	0.000378	0.000623	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PIK3CB—obesity	0.000374	0.000617	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PRKCD—obesity	0.000351	0.00058	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HTR2A—obesity	0.000344	0.000567	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—C3—obesity	0.000343	0.000566	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IRS2—obesity	0.000327	0.000539	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AGT—obesity	0.000326	0.000538	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—APOE—obesity	0.00032	0.000527	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—LEP—obesity	0.00032	0.000527	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CAV1—obesity	0.000317	0.000522	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—APOA1—obesity	0.000316	0.000521	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ESR1—obesity	0.000305	0.000503	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PRKCB—obesity	0.000301	0.000497	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—F2—obesity	0.000301	0.000497	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—BAD—obesity	0.000298	0.000491	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PIK3CG—obesity	0.000288	0.000476	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IRS1—obesity	0.000285	0.00047	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—POMC—obesity	0.000275	0.000453	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—INS—obesity	0.000273	0.00045	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCL2—obesity	0.000269	0.000443	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IGF1—obesity	0.000264	0.000436	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AKT2—obesity	0.000264	0.000435	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PIK3CD—obesity	0.000254	0.000418	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PIK3CA—obesity	0.000251	0.000414	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SERPINE1—obesity	0.000251	0.000414	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—TYK2—obesity	0.000244	0.000402	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—RHOA—obesity	0.000242	0.000399	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PIK3R1—obesity	0.000239	0.000395	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NOS3—obesity	0.000239	0.000395	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PIK3CA—obesity	0.000228	0.000376	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MTOR—obesity	0.000221	0.000365	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PIK3CB—obesity	0.000221	0.000365	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—AKT1—obesity	0.000205	0.000338	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—IL6—obesity	0.000202	0.000333	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MMP9—obesity	0.000192	0.000317	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MAPK8—obesity	0.000187	0.000308	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—AKT1—obesity	0.000186	0.000307	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—STAT3—obesity	0.000171	0.000282	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MYC—obesity	0.000159	0.000262	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—TGFB1—obesity	0.000158	0.000261	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PIK3CA—obesity	0.000135	0.000222	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IL6—obesity	0.000119	0.000197	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AKT1—obesity	0.00011	0.000182	CbGpPWpGaD
